BioAtla, Inc.
NASDAQ:BCAB
0.3844 (USD) • At close July 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 11 | 0 | 0 | 1.706 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.25 | 0.15 | 0.25 | 0 | 0 | 0.15 | 0.19 | 0.089 | 2.202 |
| Cost of Revenue
| 0 | 0 | 0 | 0.229 | 0.24 | 0.368 | 0.27 | 0.29 | 0.293 | 0.298 | 0.3 | 0.288 | 0.313 | 0.314 | 0.38 | 14.85 | 0.309 | 10.485 | 4.864 | 2.923 | 1.661 | 3.336 |
| Gross Profit
| 0 | 0 | 11 | -0.229 | -0.24 | 1.338 | -0.27 | -0.29 | -0.293 | -0.298 | -0.3 | -0.288 | -0.313 | -0.064 | -0.23 | -14.6 | -0.309 | -10.485 | -4.714 | -2.733 | -1.572 | -1.134 |
| Gross Profit Ratio
| 0 | 0 | 1 | 0 | 0 | 0.784 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.256 | -1.533 | -58.4 | 0 | -24,440,559,439.559 | -31.427 | -14.384 | -17.663 | -0.515 |
| Reseach & Development Expenses
| 12.355 | 11.65 | 16.395 | 16.198 | 18.852 | 22.674 | 28.4 | 30.96 | 21.697 | 21.874 | 19.839 | 20.711 | 16.923 | 16.448 | 16.553 | 14.85 | 10.423 | 10.485 | 4.864 | 2.923 | 1.661 | 3.336 |
| General & Administrative Expenses
| 5.259 | 4.594 | 5.875 | 5.774 | 5.605 | 5.862 | 6.62 | 6.241 | 7.233 | 6.686 | 6.34 | 8.344 | 7.423 | 7.04 | 7.142 | 15.86 | 8.374 | 5.97 | 3.301 | 1.787 | -0.463 | -0.342 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -0.229 | -0.24 | -0.368 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.259 | 4.594 | 5.875 | 5.545 | 5.365 | 5.494 | 6.62 | 6.241 | 7.233 | 6.686 | 6.34 | 8.344 | 7.423 | 7.04 | 7.142 | 15.86 | 8.374 | 5.97 | 3.301 | 1.787 | -0.463 | -0.342 |
| Other Expenses
| 0 | 0 | 0 | 0.229 | 0 | -0.027 | -0.039 | -0.011 | -0.01 | -0.03 | 0.03 | 0.003 | 0.007 | 0.002 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 |
| Operating Expenses
| 17.614 | 16.244 | 22.27 | 21.743 | 24.217 | 28.168 | 35.02 | 37.201 | 28.93 | 28.56 | 26.179 | 29.055 | 24.346 | 23.488 | 23.695 | 30.71 | 18.797 | 16.455 | 8.165 | 4.71 | 1.198 | 2.994 |
| Operating Income
| -17.614 | -16.244 | -11.27 | -21.972 | -24.457 | -28.536 | -35.02 | -37.201 | -28.93 | -28.56 | -26.179 | -29.055 | -24.346 | -23.488 | -23.695 | -30.46 | -18.797 | -16.455 | -8.015 | -4.52 | -1.109 | -0.792 |
| Operating Income Ratio
| 0 | 0 | -1.025 | 0 | 0 | -16.727 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -93.952 | -157.967 | -121.84 | 0 | -38,356,643,356.643 | -53.433 | -23.789 | -12.461 | -0.36 |
| Total Other Income Expenses Net
| 2.28 | 1.36 | 0.684 | 0.9 | 1.223 | 1.611 | 1.695 | 1.449 | 1.47 | 1.017 | 0.4 | 0.149 | 0.092 | 0.098 | 0.765 | 0.079 | 0.096 | 0.06 | -3.617 | -1.702 | -0.495 | -0.566 |
| Income Before Tax
| -15.334 | -14.884 | -10.586 | -21.072 | -23.234 | -26.925 | -33.325 | -35.752 | -27.46 | -27.543 | -25.779 | -28.906 | -24.254 | -23.39 | -22.93 | -30.381 | -18.701 | -16.395 | -11.632 | -6.222 | -1.604 | -1.358 |
| Income Before Tax Ratio
| 0 | 0 | -0.962 | 0 | 0 | -15.783 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -93.56 | -152.867 | -121.524 | 0 | -38,216,783,216.783 | -77.547 | -32.747 | -18.022 | -0.617 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0.197 | 4.934 | -2.004 | -1.46 | -1.47 | 0.218 | -0.37 | -0.146 | -0.092 | 0.002 | -0.001 | 0.08 | 0.098 | 0.001 | 0.086 | 0.754 | 0.547 | 0.506 |
| Net Income
| -15.334 | -14.884 | -10.586 | -21.072 | -23.234 | -26.925 | -33.325 | -35.752 | -25.99 | -27.761 | -25.409 | -28.76 | -24.162 | -23.39 | -22.93 | -30.381 | -18.701 | -16.395 | -11.632 | -6.222 | -1.604 | -1.361 |
| Net Income Ratio
| 0 | 0 | -0.962 | 0 | 0 | -15.783 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -93.56 | -152.867 | -121.524 | 0 | -38,216,783,216.783 | -77.547 | -32.747 | -18.022 | -0.618 |
| EPS
| -0.26 | -0.31 | -0.22 | -0.44 | -0.48 | -0.56 | -0.7 | -0.75 | -0.55 | -0.63 | -0.68 | -0.77 | -0.65 | -0.69 | -0.68 | -0.9 | -0.56 | -0.49 | -0.38 | -0.29 | -0.074 | -0.063 |
| EPS Diluted
| -0.26 | -0.31 | -0.22 | -0.44 | -0.48 | -0.56 | -0.7 | -0.75 | -0.55 | -0.63 | -0.68 | -0.77 | -0.65 | -0.69 | -0.68 | -0.9 | -0.56 | -0.49 | -0.38 | -0.29 | -0.074 | -0.063 |
| EBITDA
| -17.431 | -16.016 | -11.042 | -21.972 | -24.217 | -28.168 | -34.75 | -36.911 | -28.637 | -27.245 | -25.879 | -28.767 | -24.033 | -23.076 | -22.55 | -30.053 | -18.39 | -16.101 | -11.261 | -5.253 | -0.841 | -0.576 |
| EBITDA Ratio
| 0 | 0 | -1.004 | 0 | 0 | -16.511 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -92.304 | -150.333 | -120.212 | 0 | -37,531,468,531.469 | -75.073 | -27.647 | -9.449 | -0.262 |